日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CAG-targeted brain-permeable therapy tested in biallelic humanized polyQ mouse models.

在双等位基因人源化polyQ小鼠模型中测试了CAG靶向脑渗透性疗法

Surdyka Magdalena, Kalinowska-Pośka Żaneta, Niewiadomska-Cimicka Anna, Jesion Ewelina, Fiszer Agnieszka, Singer-Mikosch Elisabeth, Fievet Lorraine, Przybyl Lukasz, Caron Nicholas S, Hayden Michael R, Nguyen Huu Phuc, Trottier Yvon, Figiel Maciej

Longitudinal MRI and 1H-MRS study of SCA7 mouse forebrain reveals progressive multiregional atrophy and early brain metabolite changes indicating early neuronal and glial dysfunction

对SCA7小鼠前脑的纵向MRI和1H-MRS研究揭示了进行性多区域萎缩和早期脑代谢物变化,表明早期神经元和胶质细胞功能障碍。

Pérot, Jean-Baptiste; Niewiadomska-Cimicka, Anna; Brouillet, Emmanuel; Trottier, Yvon; Flament, Julien

Selective transduction of cerebellar Purkinje and granule neurons using delivery of AAV-PHP.eB and AAVrh10 vectors at axonal terminal locations

利用AAV-PHP.eB和AAVrh10载体在轴突末端进行选择性转导,从而实现对小脑浦肯野神经元和颗粒神经元的靶向转导。

Surdyka, Magdalena; Jesion, Ewelina; Niewiadomska-Cimicka, Anna; Trottier, Yvon; Kalinowska-Pośka, Żaneta; Figiel, Maciej

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion

多聚谷氨酰胺扩增引起的脊髓小脑性共济失调的基因失调及其潜在机制

Niewiadomska-Cimicka, Anna; Hache, Antoine; Trottier, Yvon

Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7

脊髓小脑性共济失调7型的分子靶点和治疗策略

Niewiadomska-Cimicka, Anna; Trottier, Yvon

Microbiological contamination in counterfeit and unapproved drugs

假冒和未经批准药物中的微生物污染

Pullirsch, Dieter; Bellemare, Julie; Hackl, Andreas; Trottier, Yvon-Louis; Mayrhofer, Andreas; Schindl, Heidemarie; Taillon, Christine; Gartner, Christian; Hottowy, Brigitte; Beck, Gerhard; Gagnon, Jacques

Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy

抑制多聚谷氨酰胺诱导的c-Jun激活可延缓SCA7视网膜病变小鼠模型中的神经元功能障碍。

Merienne, Karine; Friedman, James; Akimoto, Masayuki; Abou-Sleymane, Gretta; Weber, Chantal; Swaroop, Anand; Trottier, Yvon